Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Eli Lilly (NY:LLY)

1,041.51 -38.85 (-3.60%)
Official Closing Price Updated: 7:00 PM EST, Jan 5, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
Research
Quarterly Reports Insider Filings Other Filings

All News about Eli Lilly

< Previous 1 2 3 4 5 6 7 8 9
...
99 100 Next >
News headline image
Prediction: The S&P 500 $1 Trillion Club Will Double Between 2026 and 2030 ↗
Several companies could see massive gains by 2030 to join the vaunted club. 
Via The Motley Fool
Topics Stocks
News headline image
The 2026 Blueprint: Five Core Stocks to Anchor Your Portfolio in a Year of AI Realization
As we cross the threshold into 2026, the financial markets have entered a sophisticated new phase. The "AI Gold Rush" of 2024 and 2025 has matured into what analysts are calling the "Era of AI... 
Via MarketMinute
Topics Artificial Intelligence Economy Energy
News headline image
Should Investors Be Worried That the "Magnificent Seven" Make Up 35% of the S&P 500? ↗
At the very least, investors should be concerned. There's a way to avoid the problem, though. 
Via The Motley Fool
Topics Stocks
Novo Nordisk Offers Oral Wegovy Pill At $149 A Month Following FDA’s Approval In December: Retail Tells Shorts ‘It’s Time To Give Up’ ↗
Via Stocktwits
MarketBeat Week in Review – 12/29 - 01/02 ↗
Via MarketBeat
Top S&P500 movers in Monday's session ↗
Via Chartmill
News headline image
Flu Season's Here—This Dividend-Payer Controls the Shot Market ↗
Via MarketBeat
Topics Artificial Intelligence Death
News headline image
Bank of America Issues 2026 'Priced for Perfection' Warning: Why the S&P 500 Faces a High-Stakes 'Air Pocket'
As the financial world rings in 2026, a sobering forecast from one of Wall Street’s most influential institutions has sent a ripple of caution through the markets. Bank of America (NYSE: BAC) Global... 
Via MarketMinute
Topics Artificial Intelligence ETFs Economy
News headline image
Priced for Perfection: Bank of America Issues Stark Warning on S&P 500 Valuation for 2026
As the calendar turns to 2026, the euphoria that propelled the stock market through three consecutive years of double-digit gains is facing a sobering reality check. Bank of America (NYSE: BAC) has... 
Via MarketMinute
Topics Artificial Intelligence Economy Stocks
News headline image
These 3 Stocks Trade at Discounts the Market Won’t Ignore Forever ↗
Via MarketBeat
News headline image
Eli Lilly: Strength Meets GLP‑1 Access Momentum ↗
Eli Lilly's stock remains robust at $1,080.36 amid positive market developments, strong GLP-1 access momentum, and heightened investor interest ahead of key earnings announcements. 
Via Talk Markets
News headline image
Is It Time to Dump Your Shares of Eli Lilly? ↗
Eli Lilly has the lead in the GLP-1 race, but Novo Nordisk just changed the game. 
Via The Motley Fool
News headline image
2 Unpopular Stocks That Deserve Some Love and 1 That Underwhelm
Wall Street has issued downbeat forecasts for the stocks in this article. These predictions are rare - financial institutions typically hesitate to say bad things about a company because it can... 
Via StockStory
News headline image
4 Stocks to Buy in January That Could Join Nvidia in the $1 Trillion Club by 2030 ↗
Visa, ExxonMobil, Oracle, and Netflix have multi-year compounding potential for patient investors. 
Via The Motley Fool
Topics Artificial Intelligence
News headline image
Prediction: These Will Be the Biggest Stock Splits for 2026 ↗
Plenty of well-known companies seem ripe for stock splits -- though you shouldn't really care. 
Via The Motley Fool
News headline image
The Great 2026 Rebalancing: Institutional Giants Pivot from AI Hype to Industrial Execution
As the opening bell rang for the first trading session of 2026, the financial world witnessed the commencement of what analysts are calling "The Great Rebalancing." Institutional fund managers,... 
Via MarketMinute
Topics Artificial Intelligence Economy Stocks
News headline image
Beyond the Bot: 2026 Marks the Great Rebalancing as Investors Pivot from AI Hype to Tangible Growth
As the opening bell rings on January 2, 2026, the financial landscape looks fundamentally different from the AI-crazed atmosphere of the previous two years. The "AI Infrastructure Fever" that dominated... 
Via MarketMinute
Topics Artificial Intelligence Economy
News headline image
The 2026 Pharma Reset: How Industry Giants Are Navigating a New Era of Federal Price Controls
Yesterday marked the official commencement of the first-ever "Maximum Fair Prices" (MFPs) for ten of the most widely used drugs in the Medicare program, a direct result of the Inflation Reduction Act’s... 
Via MarketMinute
Topics Economy Intellectual Property World Trade
News headline image
The GLP-1 Pricing Revolution: How Novo Nordisk and Eli Lilly Redefined the Weight-Loss Market for 2026
As the calendar turns to 2026, the landscape for weight-loss and diabetes medication has been fundamentally transformed. What began two years ago as a "wild west" of $1,000-a-month list prices and... 
Via MarketMinute
Topics Economy Intellectual Property
News headline image
S&P 500 Tests Critical Support Levels as 2026 Kicks Off Under Technical Pressure
The S&P 500 (INDEXSP:.INX) entered the new year on a tenuous footing, grappling with a rare four-session losing streak that capped off an otherwise stellar 2025. After finishing the final trading day... 
Via MarketMinute
Topics Artificial Intelligence Economy Stocks
News headline image
$100 Invested In Eli Lilly 15 Years Ago Would Be Worth This Much Today ↗
 
Via Benzinga
News headline image
Alphabet’s Golden Year: Inside the 2025 Rally and the Future of the AI Giant
As we enter 2026, the narrative surrounding the world’s most dominant information gateway has shifted from one of existential threat to unprecedented strength. Alphabet Inc. (NASDAQ: GOOGL / GOOG) has... 
Via PredictStreet
Topics Artificial Intelligence Initial Public Offering
News headline image
2 S&P 500 Stocks with Impressive Fundamentals and 1 We Avoid
While the S&P 500 (^GSPC) includes industry leaders, not every stock in the index is a winner. Some companies are past their prime, weighed down by poor execution, weak financials, or structural... 
Via StockStory
Topics Stocks
News headline image
The $3 Billion Bet: How Isomorphic Labs is Rewriting the Rules of Drug Discovery with Eli Lilly and Novartis
In a move that has fundamentally reshaped the landscape of the pharmaceutical industry, Isomorphic Labs—the London-based drug discovery arm of Alphabet Inc. (NASDAQ: GOOGL)—has solidified its position... 
Via TokenRing AI
Topics Artificial Intelligence
News headline image
The Great Unlocking: How AlphaFold 3’s Open-Source Pivot Sparked a New Era of Drug Discovery
The landscape of biological science underwent a seismic shift in November 2024, when Google DeepMind, a subsidiary of Alphabet Inc. (NASDAQ: GOOGL), officially released the source code and model... 
Via TokenRing AI
Topics Artificial Intelligence
News headline image
Pfizer’s Dividend Trap or Deep Value? Analyzing the Pharma Giant as Shares Languish Below $30
As the calendar turns to January 1, 2026, Pfizer Inc. (NYSE: PFE) finds itself in a position that would have been unthinkable during the height of the pandemic. Once the darling of the pharmaceutical... 
Via MarketMinute
Topics Intellectual Property
News headline image
Navigating the Neutral Rate: Wall Street's 2026 Outlook Forecasts Growth Amidst AI Maturity
As the opening bell prepares to ring for the first time in 2026, the American investor finds themselves at a unique crossroads of technological maturation and economic normalization. Following a robust... 
Via MarketMinute
Topics Artificial Intelligence Bonds Economy
News headline image
The Evolution of a Healthcare Giant: Abbott Laboratories (ABT) 2026 Stock Feature
As of today, January 1, 2026, Abbott Laboratories (NYSE: ABT) stands as one of the most resilient and strategically diversified giants in the global healthcare landscape. While the broader market has... 
Via PredictStreet
Topics Economy Lawsuit World Trade
News headline image
Forget Recursion Pharmaceuticals Stock. This Is a Much Better Buy. ↗
These two companies have very different risk-reward profiles. 
Via The Motley Fool
Topics Artificial Intelligence
News headline image
Where Will Pfizer Be in 5 Years? ↗
Pfizer's stock is down roughly 60% from its late 2021 highs, but the drug giant is working to innovate its way back into the big leagues. 
Via The Motley Fool
Topics Intellectual Property
< Previous 1 2 3 4 5 6 7 8 9
...
99 100 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.